ALIGOS THERAPEUTICS INC's ticker is ALGS and the CUSIP is 01626L105. A total of 78 filers reported holding ALIGOS THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $2,145,000 | -9.1% | 1,950,000 | 0.0% | 0.10% | -12.1% |
| Q2 2022 | $2,360,000 | -43.7% | 1,950,000 | 0.0% | 0.12% | -47.5% |
| Q1 2022 | $4,193,000 | -86.5% | 1,950,000 | -25.4% | 0.22% | -85.0% |
| Q4 2021 | $31,035,000 | -23.5% | 2,614,563 | 0.0% | 1.47% | -30.0% |
| Q3 2021 | $40,552,000 | -23.9% | 2,614,563 | 0.0% | 2.10% | -11.3% |
| Q2 2021 | $53,311,000 | -10.3% | 2,614,563 | 0.0% | 2.36% | -3.7% |
| Q1 2021 | $59,455,000 | -17.8% | 2,614,563 | 0.0% | 2.46% | -20.8% |
| Q4 2020 | $72,293,000 | – | 2,614,563 | – | 3.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 2,320,381 | $47,301,000 | 15.67% |
| Pivotal bioVenture Partners Investment Advisor LLC | 876,548 | $17,873,000 | 7.04% |
| Vivo Capital, LLC | 3,547,030 | $72,306,000 | 3.13% |
| Novo Holdings A/S | 2,614,563 | $53,311,000 | 2.36% |
| ACUTA CAPITAL PARTNERS, LLC | 214,254 | $4,368,000 | 1.75% |
| Boxer Capital, LLC | 1,526,048 | $31,108,000 | 1.10% |
| VR Adviser, LLC | 408,377 | $8,325,000 | 1.01% |
| Cormorant Asset Management, LP | 905,467 | $18,458,000 | 0.63% |
| HHLR ADVISORS, LTD. | 2,165,064 | $44,135,000 | 0.45% |
| Logos Global Management LP | 212,785 | $4,339,000 | 0.36% |